Clinical trials
Phase 2 trials in Kazakhstan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 1 |
| Industrial Microbiology LLP | 1 |
| Kazakh National Agrarian University | 1 |
| Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 1 |
| National Scientific Medical Center, Kazakhstan | 1 |
| Ralf Rothoerl | 1 |
| Research Institute for Biological Safety Problems | 1 |
| Scientific Center for Anti-infectious Drugs, Kazakhstan | 1 |
| St. Petersburg State Pavlov Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 1 |
| COVID-19 | 1 |
| Coronary Artery Disease | 1 |
| Crohn Disease | 1 |
| Dysbiosis | 1 |
| Erectile Dysfunction | 1 |
| Heart Failure | 1 |
| Hodgkin Disease | 1 |
| Inflammatory Bowel Diseases | 1 |
| Influenza, Human | 1 |
Trials
Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.